October 15, 2019
Falls are the leading cause of fatal and nonfatal injuries for older Americans, but hospitals seeking to prevent falls are facing a conundrum over whether patients should remain bedbound to avoid dangers or move to regain their mobility.
Health systems across the country are testing ways to help patients who are healthy enough to leave the hospital but lack a safe place to go after discharge.
October 14, 2019
Medscape on Wednesday released its annual RN/LPN Compensation report, and this year's report shows that 49% of registered nurses and 58% of licensed practical nurses do not feel fairly compensated.
October 11, 2019
Colorado officials on Monday released a draft report outlining a proposed state public health insurance option, but the plan is drawing criticism from health care providers who would receive lower reimbursements under the proposal.
American Health Line rounds up the latest health care news in the states.
October 10, 2019
HHS on Wednesday issued long-anticipated proposed rules to update anti-kickback and physician-referral regulations so they do not interfere with physicians' ability to participate in value-based payment arrangements.
U.S. News & World Report last week released its "Best States for Aging" list, which ranks all 50 states on how they address the needs of older adults. See how your state fared on our interactive map.
The number of U.S. residents diagnosed with a sexually transmitted infection (STI) hit a record high in 2018, with almost 2.46 million reported cases of chlamydia, gonorrhea, syphilis, and other STIs, according to a CDC report released Tuesday.
A new Institute for Clinical and Economic Review report found drugmakers between 2017 and 2018 increased the prices of seven drugs without clinical evidence to justify the increases, costing patients and insurers more than $5 billion—but drugmakers are questioning the report's accuracy.
A Philadelphia jury on Tuesday ordered New Jersey-based Johnson & Johnson (J&J) to pay $8 billion in punitive damages to a Maryland man who claimed J&J failed to properly warn patients and providers that its antipsychotic drug Risperdal could spur breast growth in boys.
Advisory Board. All rights reserved.